FLKS News

Ten IPOs raised $1.2 billion in a week dominated by eight health care IPOs and distinguished by two deals that gained over 100% on the first day - fast casual burger chain Shake Shack and gene therapy biotech Spark Therapeutics. There were more health care IPOs this past week than any week in 2014, a year that had over 100 from the sector. With 14 IPOs to date, January 2015 fell...read more

Flex Pharma, which is developing dietary supplements for the treatment of muscle cramps and spasms, raised $86 million by offering 5.4 million shares at $16, above the range of $12 to $14. The company originally planned to offer 4.6 million shares. Flex Pharma plans to list on the NASDAQ under the symbol FLKS. Flex Pharma initially filed confidentially on 10/29/2014. Jefferies...read more

Twelve IPOs are set to raise $1 billion in the upcoming week, which would make it the busiest five-day stretch for IPOs since the week of July 28. Shake Shack's IPO offers investors a chance to own a fast-growing fast casual concept based in New York. Ten of the twelve deals are health care, as last year's most popular sector continues to outperform. Assuming they all price, there...read more

Flex Pharma, which is developing dietary supplements for the treatment of muscle cramps and spasms, announced terms for its IPO on Tuesday. The Boston, MA-based company plans to raise $60 million by offering 4.6 million shares at a price range of $12 to $14. At the midpoint of the proposed range, Flex Pharma would command a fully diluted market value of $231 million. Flex...read more